About this Event
You are invited to a special event on Tuesday, November 17 to learn more about the impact of your PMC fundraising on advancements in thoracic oncology at Dana-Farber. Light refreshments will be served.
Event Schedule
5:30 pm - Mix, mingle, and enjoy food and drinks with fellow PMC riders, volunteers, and sponsors
6:00 pm - Speaking Program and Q&A featuring Dr. Matthew G. Oser MD, PhD
6:45 pm - Opportunity to tour the lab of Dr. Oser
7:30 pm - Event concludes
About Dr. Matthew G. Oser, MD, PhD
Associate Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School
Matthew G. Oser MD, PhD, is an Associate Professor of Medicine at Harvard Medical School and a medical oncologist at Dana-Farber Cancer Institute in the Lowe Center for Thoracic Oncology. Dr. Oser completed his undergraduate studies at Oberlin College and received his MD and PhD degrees from the Albert Einstein College of Medicine. He completed a residency in Internal Medicine at Brigham and Women’s Hospital followed by a fellowship in Medical Oncology at the Dana-Farber Cancer Institute/Mass General Brigham where he did his postdoctoral research with Dr. William G. Kaelin Jr. Dr. Oser is a member of the American Society of Clinical Investigation and has received several awards including a Damon Runyon Clinical Investigator Award, an ACS Research Scholar Award, and an R37 MERIT award. Dr. Oser has been invited to give national and international seminars at several academic institutions and conferences, and has published his research in several high impact journals including Nature, Cancer Cell, Nature Cell Biology, and Cancer Discovery. Dr. Oser’s research laboratory at the Dana-Farber Cancer Institute uses CRISPR/Cas9-based functional genomics and genetically engineered models to define the mechanisms that promote small cell lung cancer (SCLC) growth and therapeutic resistance. His laboratory focuses on lineage transcription factor dependencies, neuroendocrine differentiation and lineage plasticity, and mechanisms of tumor immune evasion, with the goal of identifying new therapeutic vulnerabilities and developing novel treatments for SCLC.
Complimentary parking will be available in the Yawkey Garage (1 Jimmy Fund Way, Boston). Parking will be validated upon arrival to the event.
We strive to host inclusive, accessible events that enable attendees to engage fully. Please contact us if you would like to discuss any accommodation needs or if you have any other questions.
Event venue & nearby stays
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, United States
Concerts, fests, parties, meetups — all the happenings, one place.